Zhang, Guangbing
Guo, Cuiyu
Wang, Yan
Zhang, Xianda
Liu, Shuang
Qu, Wen
Chen, Chunxia
Yan, Lingli
Yang, Zhouning
Zhang, Zhixiong
Jiang, Xiaohua
Chen, Xiaofeng
Liu, Hong
Lai, Qinhuai
Wei, Xian
Lu, Ying
Zhao, Shengyan
Deng, Han
Wang, Yuxi
Yu, Lin
Yu, Hongbin
Wu, Yu
Su, Zhaoming
Chen, Pengyu
Ren, Ziqing
Yu, Meng
Qu, Feng
Luo, Yong
Gou, Lantu
Li, Qing
Huang, Ying
Ma, Fanxin
Yang, Jinliang
Funding for this research was provided by:
Sichuan Science and Technology Program (2021YJ0454, 2019YFS0003)
National Natural Science Foundation of China (32070049, 81872907)
Ministry of Science and Technology of China (2021YFA1301900)
Sichuan University start-up funding (20822041D4057)
Science and Technology Plan Project of Sichuan Province (2020YFSY0025)
the CAMS Innovation Fund for Medical Sciences (2021-I2M-5-075)
the National Major Scientific and Technological Special Project for Significant New Drugs Development (2018ZX09201018-021)
Article History
Received: 24 October 2022
Accepted: 20 December 2022
First Online: 29 December 2022
Declarations
:
: The human subject studies were approved by the Ethnic Committee of West China Hospital of Sichuan University. All patients provided written informed consent.
: Not applicable.
: Qing Li, Ying Huang, Fanxin Ma, Xianda Zhang, Shuang Liu, Zhouning Yang, Pengyu Chen, Ziqing Ren, Meng Yu, and Feng Qu are employees at Sound Biopharmaceuticals Co., Ltd. No potential conflicts of interest were disclosed by the other authors.